HHGC
AGN

Hunting Hill Global Capital’s Allergan plc AGN Stock Holding History

Hunting Hill Global Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-400,000
Closed -$76.5M – 34
2019
Q4 		$76.5M Sell
400,000
-50,000
-11% -$9.02M 17.14% 1
2019
Q3 		$75.7M Buy
450,000
+100,000
+29% +$16.3M 18.96% 1
2019
Q2 		$58.6M Buy
+350,000
New +$48.5M 9.72% 4

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Hunting Hill Global Capital's AGN Position: Q2 2020 in Review

Hunting Hill Global Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 145,000 shares — an estimated $25.7M sold.

Hunting Hill Global Capital first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $68.3M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Hunting Hill Global Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Hunting Hill Global Capital sold 145,000 Allergan plc shares in Q2 2020, an estimated $25.7M.
  • Hunting Hill Global Capital first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Hunting Hill Global Capital's Allergan plc position peaked at $68.3M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Hunting Hill Global Capital's 13F filing for Q2 2020, filed 14 Aug 2020.